Cancer Therapy & Radiation Oncology

Combination Therapies in Metastatic Cancer Management

Combination therapies are redefining the management of metastatic cancer by integrating radiation therapy with systemic treatments such as immunotherapy, targeted therapy, and chemotherapy. This session focuses on synergistic treatment strategies designed to enhance tumor response while addressing tumor heterogeneity and resistance mechanisms. The biological rationale behind radiation-induced immune modulation and the abscopal effect will be examined alongside clinical evidence supporting combined modality approaches. Emerging therapies including antibody-drug conjugates and novel checkpoint inhibitors are expanding treatment possibilities in advanced disease settings. Experts will discuss optimal sequencing, dosing strategies, and toxicity management to ensure patient safety. Real-world data and ongoing clinical trials will highlight improved survival and quality-of-life outcomes. By leveraging multidisciplinary collaboration, combination therapies offer promising advancements in controlling metastatic disease and extending patient survival on a global scale.